| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS | 2 | 2 | -0,08 % | ||
| CMB.TECH | 1 | 1 | 0,00 % | ||
| DEME GROUP | - | 5 | -1,11 % | ||
| PROXIMUS | - | 4 | -0,23 % | ||
| BEKAERT | - | 2 | 0,00 % | ||
| COLRUYT GROUP | - | 2 | -0,52 % | ||
| VGP NV | - | 1 | -0,63 % | ||
| TINC | - | 1 | -0,17 % | ||
| BARCO | - | - | -0,76 % | ||
| ION BEAM APPLICATIONS | - | - | -0,12 % |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Lakefront BioTherapeutics launches €50M share buyback program | 1 | Seeking Alpha | ||
| Di | Lakefront Biotherapeutics: Lakefront Announces Initiation of €50 Million Stock Repurchase Program | 270 | GlobeNewswire (Europe) | Mechelen, Belgium; June 9, 2026, 22:01 CET; regulated information - Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced
the launch of a share repurchase program (the "Program")... ► Artikel lesen | |
| Di | CMB.Tech Reports Q1 2026 Results: Full Earnings Call Transcript | 5 | Benzinga.com | ||
| Mo | Lakefront Biotherapeutics: Lakefront Appoints Eric Hedrick, MD, as Chief Medical Officer | 142 | GlobeNewswire (Europe) | Mechelen, Belgium; June 8, 2026, 22:01 CET; Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced that Eric Hedrick, MD has been appointed Chief Medical Officer. This expanded leadership... ► Artikel lesen | |
| Mo | CARE PROPERTY INVEST: Withdrawal of the optional dividend offer | 1 | Euronext | ||
| Mo | EVS Broadcast Equipment Rebrands, Trims Its Name | 2 | tvtech | ||
| Mo | EVS Broadcast Equipment evolves its brand to reflect its transformation into a global live video technology leader | 301 | GlobeNewswire (Europe) | By simplifying its corporate name from EVS Broadcast Equipment to EVS, the company signals a broader strategic vision, expanded market reach, and the continued strength of its globally recognized brand.
EVS... ► Artikel lesen | |
| Mo | Gilead Sciences und Lakefront Biotherapeutics schließen Übernahme von Ouro Medicines ab und bauen damit ihre Entzündungspipeline weiter aus | 2 | Bionity.com | ||
| Mo | IBA SA: IBA signs contract with a major U.S. academic medical center to install two ProteusONE proton therapy solutions | 22 | GlobeNewswire (USA) | ||
| Fr | Gilead Sciences, Lakefront Biotherapeutics Acquire Ouro Medicines | 9 | Contract Pharma | ||
| Fr | Lakefront Biotherapeutics NV - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| Fr | Jan De Nul beats DEME for multi-billion-dollar contract on Argentine waterway | 2 | belga | ||
| Fr | Bekaert - Update on the Share Buyback Program and Liquidity Agreement | 2 | GlobeNewswire (USA) | ||
| Do | Gilead, Lakefront Biotherapeutics complete Ouro Medicines acquisition | 6 | Seeking Alpha | ||
| Do | Gilead and Lakefront Biotherapeutics complete Ouro Medicines acquisition | 5 | Investing.com | ||
| Do | Gilead Sciences, Inc.: Gilead Sciences and Lakefront Biotherapeutics Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline | 1.314 | Business Wire | - Companies will collaborate on the development of gamgertamig, a potential first-in-class and best-in-class T cell engager in autoimmune diseases -
Gilead Sciences, Inc. (Nasdaq: GILD) and Lakefront... ► Artikel lesen | |
| Do | DEME wins OMMP dredging contract for three Tunisian port areas | 3 | PortNews | ||
| 03.06. | Fagron NV: Disclosure of transparency notification from FMR LLC | 2 | GlobeNewswire (USA) | ||
| 03.06. | DEME Group NV: DEME secures dredging contract to enhance access to strategic Tunisian ports | 2 | GlobeNewswire (USA) | ||
| 03.06. | Colruyt Expands In-Store Bakery Range To Ten Shops In Belgium | 2 | ESM Magazine |